Saint Luke's Hospital, Kansas City (United States of America)
Follow
Contributor content
Presentation
Hospitalization-related costs among patients with atrial fibrillation treated with the factor Xa inhibitor edoxaban vs warfarin: results from the ENGAGE AF-TIMI 48 trial
